Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shizuo Shiozaki is active.

Publication


Featured researches published by Shizuo Shiozaki.


Acta Oto-laryngologica | 1988

Effects of Flunarizine on Induced Nystagmus and Cochlear Blood Flow

Shizuo Shiozaki; Kazuhiro Kubo; Katsuichi Shuto; Tetsuo Oka; Nobuhiro Nakamizo

The effects of flunarizine on induced nystagmus and cochlear blood flow were compared with those of cinnarizine and diphenidol. Flunarizine significantly inhibited caloric (cool water)-induced nystagmus frequency and duration of nystagmus in rabbits at 5 mg/kg i.v., whereas cinnarizine and diphenidol only slightly decreased the frequency of nystagmus at 5 mg/kg, i.v. As for optokinetic stimuli-induced nystagmus in rabbits, flunarizine significantly decreased the amplitude of nystagmus at 2.5 mg/kg i.v., and cinnarizine and diphenidol inhibited nystagmus at 5 mg/kg, i.v. Flunarizine had no effect on nystagmus induced by electrical stimulation of the lateral geniculate body in rabbits at doses up to 5 mg/kg, i.v. Flunarizine increased the cochlear blood flow in anesthetized guinea pigs dose-dependently (0.312-1.25 mg/kg i.v.) On the other hand, cinnarizine (0.625-2.5 mg/kg i.v.) and diphenidol (0.625-2.5 mg/kg i.v.) increased cochlear blood flow, but the duration of action of both cinnarizine and diphenidol was shorter than that of flunarizine at the same dose. As stated above, flunarizine inhibited nystagmus experimentally induced by caloric or optokinetic stimuli. Increased cochlear blood flow suggested that the enhancement of vestibular blood flow might play an important role in the treatment of vestibular dysfunctions with this drug.


Journal of pharmacobio-dynamics | 1980

Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA.

Katsuichi Shuto; Shizuo Shiozaki; Tetsuo Kojima; Masao Tanaka


Archive | 1988

Anti-dementia agent

Shizuo Shiozaki; Katsuichi Shuto; Yoshimasa Oiji


Folia Pharmacologica Japonica | 1982

Effects of flunarizine on nystagmus and cochlear blood flow

Shizuo Shiozaki; Kazuhiro Kubo; Katsuichi Shuto; Nobuhiro Nakamizo


Journal of pharmacobio-dynamics | 1980

Effects of KW-5338 (domperidone) on gastric motility.

Katsuichi Shuto; Shizuo Shiozaki; Tetsuo Kojima; Masao Tanaka


Japanese Journal of Pharmacology | 1975

PHARMACOLOGICAL STUDIES OF CAERULEIN II. THE POSSIBILITY OF MEDIATION THROUGH THE CENTRAL NERVOUS SYSTEM

Nobuo Nakamura; Shizuo Shiozaki; Yoshihisa Koyama; Tetsuo Kojima; Hirofuto Marumo


Folia Pharmacologica Japonica | 1977

[Effects of caerulein on intestinal motility (author's transl)].

Nobuo Nakamura; Shizuo Shiozaki; Tetsuo Kojima; Motoaki Shimizu; Masao Tanaka


Archive | 1988

Using benzylpyridine derivatives for the preparation of a medicament for the treatment of dementia.

Shizuo Shiozaki; Katsuichi Shuto; Yoshimasa Oiji


Archive | 1988

Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz. Using benzylpyridine derivatives for the preparation of a medicament for the treatment of dementia.

Shizuo Shiozaki; Katsuichi Shuto; Yoshimasa Oiji


Archive | 1988

Use of benzylpyridine derivatives in the manufacture of a medicament for the treatment of dementia

Shizuo Shiozaki; Katsuichi Shuto; Yoshimasa Oiji

Collaboration


Dive into the Shizuo Shiozaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge